Cytokinetics Inc
Statements
Cash Flow
Cytokinetics Inc (CYTK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -160 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12 | 78 | -21 | -31 | -25 | -24 | -30 | -27 | -32 | -12 | -27 | -25 | -20 | -19 | -30 | -27 | 14 | 52 | -30 | -29 | -39 | -45 | -27 | -90 | -82 | -98 | -122 | -122 | -96 | -74 | -130 | -99 | -102 | -66 | -132 | -128 | -108 | -143 | -145 | -160 | -555 | |
| 0.2 | 0.2 | 0.4 | 0.4 | 0.5 | 0.6 | 0.7 | 0.6 | 0.3 | -0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.7 | 1.3 | 1.4 | 2.1 | 1.7 | 2.8 | 1.9 | 1.9 | 6.3 | 2.3 | 2.4 | 2.4 | 2.4 | 2.3 | 2.3 | 2.7 | 2.9 | 3.4 | 3.6 | 13 | |
| 1.9 | 1.9 | 1.9 | 2.2 | 2.4 | 2.4 | 2.4 | 2.5 | 2.6 | 9.8 | 2.3 | 2.8 | 2.8 | 11 | 3.5 | 4.5 | 4.7 | 4.9 | 5.3 | 7.1 | 7.8 | 6.7 | 9.0 | 12 | 13 | 13 | 15 | 19 | 19 | 19 | 22 | 25 | 25 | 26 | 24 | 28 | 31 | 31 | 30 | 36 | 127 | |
| 2.0 | 2.0 | 1.8 | 2.2 | 2.4 | 2.5 | 6.8 | 6.7 | 6.2 | 9.8 | 6.8 | 7.5 | 8.0 | 12 | 3.5 | 4.5 | 4.7 | 11 | 5.3 | 13 | 7.8 | 14 | 12 | 12 | 36 | 19 | 22 | 29 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -46 | 67 | 0.2 | -8.7 | -0.1 | 9.1 | -7.0 | -6.6 | -17 | 7.4 | -4.6 | -0.4 | 0.9 | 3.7 | -2.4 | 1.2 | 2.5 | 85 | 5.2 | 17 | 21 | -34 | 40 | -94 | 12 | 17 | -19 | -24 | 1.5 | 45 | -26 | 9.8 | 9.9 | 42 | -5.2 | -51 | 23 | -1.8 | -0.2 | -25 | -4.8 | |
| 0.3 | 0.9 | 1.4 | 0.3 | 0.5 | 0.8 | 0.3 | 0.1 | 0.4 | 0.2 | 0.3 | 0.1 | 1.0 | 1.3 | 1.0 | 0.9 | 2.6 | 6.6 | 6.6 | 8.8 | 16 | 18 | 0.9 | 0.9 | 6.3 | 3.2 | 0.4 | 0.7 | 0.2 | 0.1 | 1.8 | 1.9 | 2.5 | 1.3 | 5.7 | 4.1 | 9.4 | 5.6 | 5.9 | 4.3 | 25 | |
| 14 | -42 | -112 | -24 | 40 | 31 | 20 | -44 | 2.7 | 27 | 20 | -2.8 | 14 | -105 | 43 | 35 | -101 | -174 | -5.3 | 19 | -209 | 47 | -64 | 65 | -292 | 29 | 165 | 82 | 73 | -81 | 33 | -652 | -45 | 111 | 106 | 53 | -71 | -71 | 145 | -507 | -504 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.7 | 0.7 | 18 | 107 | 1.4 | 0.9 | -0.5 | 3.0 | 0.3 | 0.5 | 4.4 | 20 | 11 | 1.4 | – | 2.0 | 37 | 3.6 | 3.6 | – | – | 19 | -9.6 | 3.7 | 1.8 | 18 | -11 | – | – | 15 | 30 | – | 17 | – | – | 14 | 21 | – | 11 | – | – | |
| – | 15 | 1.3 | 1.3 | 1.3 | 1.3 | 9.9 | 9.9 | 9.9 | 1.7 | 1.7 | 1.7 | 134 | 134 | – | – | – | – | – | -48 | -48 | -48 | -50 | -0.3 | 524 | -0.1 | -0.2 | -0.2 | – | – | – | – | -2.9 | -2.9 | -2.9 | -2.7 | 324 | -2.7 | -2.7 | -3.6 | 315 | |
| 0.7 | 0.7 | 116 | 107 | 1.4 | 2.2 | -0.5 | 3.0 | 10 | 0.5 | 4.4 | 22 | 12 | 121 | 0.0 | 4.1 | 226 | 3.6 | -3.6 | 3.2 | 301 | 20 | 94 | 3.4 | 387 | 30 | -7.2 | 5.5 | 54 | 169 | 104 | 821 | 3.4 | 2.4 | 4.8 | 79 | 330 | 111 | 7.8 | 793 | 1,242 | |
| 2.6 | 37 | -18 | 51 | 16 | 8.9 | -10 | -68 | -19 | 15 | -2.8 | -5.0 | 5.3 | -3.2 | 13 | 11 | 140 | -118 | -38 | -7.4 | 53 | 22 | 2.8 | -22 | 13 | -41 | 38 | -34 | 31 | 13 | 7.0 | 70 | -143 | 48 | -21 | 2.5 | 152 | -103 | 7.3 | 125 | 182 | |
| -12 | 77 | -22 | -32 | -26 | -25 | -30 | -27 | -33 | -13 | -27 | -25 | -21 | -20 | -31 | -28 | 12 | 46 | -36 | -38 | -54 | -62 | -28 | -91 | -88 | -101 | -123 | -123 | -96 | -74 | -128 | -101 | -104 | -67 | -137 | -132 | -117 | -148 | -151 | -164 | -581 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.